These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
170 related items for PubMed ID: 24018177
1. Impact of azithromycin treatment on macrophage gene expression in subjects with cystic fibrosis. Cory TJ, Birket SE, Murphy BS, Hayes D, Anstead MI, Kanga JF, Kuhn RJ, Bush HM, Feola DJ. J Cyst Fibros; 2014 Mar; 13(2):164-71. PubMed ID: 24018177 [Abstract] [Full Text] [Related]
2. Azithromycin reduces exaggerated cytokine production by M1 alveolar macrophages in cystic fibrosis. Meyer M, Huaux F, Gavilanes X, van den Brûle S, Lebecque P, Lo Re S, Lison D, Scholte B, Wallemacq P, Leal T. Am J Respir Cell Mol Biol; 2009 Nov; 41(5):590-602. PubMed ID: 19244203 [Abstract] [Full Text] [Related]
3. Azithromycin Augments Bacterial Uptake and Anti-Inflammatory Macrophage Polarization in Cystic Fibrosis. Tarique AA, Tuladhar N, Kelk D, Begum N, Lucas RM, Luo L, Stow JL, Wainwright CE, Bell SC, Sly PD, Fantino E. Cells; 2024 Jan 16; 13(2):. PubMed ID: 38247856 [Abstract] [Full Text] [Related]
4. Azithromycin drives alternative macrophage activation and improves recovery and tissue sparing in contusion spinal cord injury. Zhang B, Bailey WM, Kopper TJ, Orr MB, Feola DJ, Gensel JC. J Neuroinflammation; 2015 Nov 24; 12():218. PubMed ID: 26597676 [Abstract] [Full Text] [Related]
5. Transcriptional and functional diversity of human macrophage repolarization. Gharib SA, McMahan RS, Eddy WE, Long ME, Parks WC, Aitken ML, Manicone AM. J Allergy Clin Immunol; 2019 Apr 24; 143(4):1536-1548. PubMed ID: 30445062 [Abstract] [Full Text] [Related]
6. Predictive screening of M1 and M2 macrophages reveals the immunomodulatory effectiveness of post spinal cord injury azithromycin treatment. Gensel JC, Kopper TJ, Zhang B, Orr MB, Bailey WM. Sci Rep; 2017 Jan 06; 7():40144. PubMed ID: 28057928 [Abstract] [Full Text] [Related]
7. Effects of prolonged use of azithromycin in patients with cystic fibrosis: a meta-analysis. Florescu DF, Murphy PJ, Kalil AC. Pulm Pharmacol Ther; 2009 Dec 06; 22(6):467-72. PubMed ID: 19328860 [Abstract] [Full Text] [Related]
8. Long term azithromycin therapy in patients with cystic fibrosis. Emiralioğlu N, Öztürk Z, Yalçın E, Doğru D, Özçelik U, Kiper N. Turk J Pediatr; 2016 Dec 06; 58(1):34-40. PubMed ID: 27922234 [Abstract] [Full Text] [Related]
9. The Potential for QT Interval Prolongation with Chronic Azithromycin Therapy in Adult Cystic Fibrosis Patients. Avedissian SN, Rhodes NJ, Ng TMH, Rao AP, Beringer PM. Pharmacotherapy; 2019 Jun 06; 39(6):718-723. PubMed ID: 31045258 [Abstract] [Full Text] [Related]
11. The role of azithromycin in patients with cystic fibrosis. Yousef AA, Jaffe A. Paediatr Respir Rev; 2010 Jun 06; 11(2):108-14. PubMed ID: 20416547 [Abstract] [Full Text] [Related]
12. Anti-inflammatory effects of azithromycin in cystic fibrosis airway epithelial cells. Cigana C, Nicolis E, Pasetto M, Assael BM, Melotti P. Biochem Biophys Res Commun; 2006 Dec 01; 350(4):977-82. PubMed ID: 17045242 [Abstract] [Full Text] [Related]
13. Concerns regarding the safety of azithromycin in pregnancy - relevance for women with cystic fibrosis. Taylor-Cousar JL, Jain R, Kazmerski TM, Aitken ML, West NE, Wilson A, Middleton PG, Nash EF. J Cyst Fibros; 2021 May 01; 20(3):395-396. PubMed ID: 32800485 [Abstract] [Full Text] [Related]
14. Once-weekly azithromycin in cystic fibrosis with chronic Pseudomonas aeruginosa infection. Steinkamp G, Schmitt-Grohe S, Döring G, Staab D, Pfründer D, Beck G, Schubert R, Zielen S. Respir Med; 2008 Nov 01; 102(11):1643-53. PubMed ID: 18701270 [Abstract] [Full Text] [Related]
15. Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial. Equi A, Balfour-Lynn IM, Bush A, Rosenthal M. Lancet; 2002 Sep 28; 360(9338):978-84. PubMed ID: 12383667 [Abstract] [Full Text] [Related]
16. Porcine alveolar macrophage polarization is involved in inhibition of porcine reproductive and respiratory syndrome virus (PRRSV) replication. Wang L, Hu S, Liu Q, Li Y, Xu L, Zhang Z, Cai X, He X. J Vet Med Sci; 2017 Nov 20; 79(11):1906-1915. PubMed ID: 28924090 [Abstract] [Full Text] [Related]
17. Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosa. Cory TJ, Birket SE, Murphy BS, Mattingly C, Breslow-Deckman JM, Feola DJ. J Antimicrob Chemother; 2013 Apr 20; 68(4):840-51. PubMed ID: 23248239 [Abstract] [Full Text] [Related]
18. Differential expression of inflammatory and anti-inflammatory mediators by M1 and M2 macrophages after photobiomodulation with red or infrared lasers. de Brito Sousa K, Rodrigues MFSD, de Souza Santos D, Mesquita-Ferrari RA, Nunes FD, de Fátima Teixeira da Silva D, Bussadori SK, Fernandes KPS. Lasers Med Sci; 2020 Mar 20; 35(2):337-343. PubMed ID: 31152259 [Abstract] [Full Text] [Related]
19. Steady-State Therapy with Azithromycin or Low-Dose Prednisolone in Paediatric Cystic Fibrosis Patients: Inflammatory Markers and Disease Progression. Shmarina G, Pukhalsky A, Avakian L, Semykin S, Pukhalskaya D, Alioshkin V. Int Arch Allergy Immunol; 2017 Mar 20; 172(1):45-54. PubMed ID: 28219060 [Abstract] [Full Text] [Related]
20. Azithromycin maintenance therapy in patients with cystic fibrosis: a dose advice based on a review of pharmacokinetics, efficacy, and side effects. Wilms EB, Touw DJ, Heijerman HG, van der Ent CK. Pediatr Pulmonol; 2012 Jul 20; 47(7):658-65. PubMed ID: 22684985 [Abstract] [Full Text] [Related] Page: [Next] [New Search]